ArticleVaccines2020

Targeted Alteration of Antibody-Based Immunodominance Enhances the Heterosubtypic Immunity of an Experimental PCV2 Vaccine.

Agm Rakibuzzaman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.